Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...

MRD-negative response rate in four patients; all remain in response through the longest follow up of 5 monthsFavorable ...

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...

The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found additional appropriate patients beyond that. "The analysis was unambiguous: ...

Cullinan Therapeutics (CGEM) shared updated clinical data from its Phase 1 study of CLN-049, a novel, investigational FLT3xCD3 bispecific T cell ...

Senti Bio (SNTI)sciences announced new data from its ongoing multinational, multicenter clinical trial of SENTI-202, a first-in-class CD33/FLT3 ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

ANAHEIM, Calif.--(BUSINESS WIRE)--Truvian Health, a transformational and data-driven diagnostics company, today presented results from a recent multi-site clinical study at the 2023 American ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

Participants in clinical trials donate their health information so researchers can learn more about the risks and benefits of new treatments. During a clinical study, all kinds of personal information ...